Provided by Tiger Trade Technology Pte. Ltd.

Artelo Biosciences, Inc.

6.24
+0.27574.62%
Volume:560.99K
Turnover:3.42M
Market Cap:3.42M
PE:-0.06
High:6.79
Open:6.06
Low:5.34
Close:5.96
52wk High:249.75
52wk Low:4.68
Shares:547.78K
Float Shares:547.42K
Volume Ratio:0.87
T/O Rate:102.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-102.4149
EPS(LYR):-337.9329
ROE:-705.71%
ROA:-127.92%
PB:0.68
PE(LYR):-0.02

Loading ...

Company Profile

Company Name:
Artelo Biosciences, Inc.
Exchange:
NASDAQ
Establishment Date:
2011
Employees:
- -
Office Location:
505 Lomas Santa Fe,Suite 160,Solana Beach,California,United States
Zip Code:
92075
Fax:
- -
Introduction:
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for treating breast and prostate cancer, neuropathic and nociceptive pain, and anxiety disorders, including PTSD. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.

Directors

Name
Position
Gregory D. Gorgas
President,Chief Executive Officer,Secretary and Director
Connie Matsui
Chairperson of the Board and Independent Director
Douglas Blayney
Independent Director
Greg Reyes
Independent Director
R. Martin Emanuele
Independent Director
Steven Kelly
Independent Director
Tamara A. Favorito
Independent Director

Shareholders

Name
Position
Gregory D. Gorgas
President,Chief Executive Officer,Secretary and Director
Mark Spring
Chief Financial Officer and Treasurer